An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Affiliated Hospital Nantong University, Nantong, Jiangsu, China
Mansoura University,Mansoura University Hospitals, Mansoura, Dakahlia, Egypt
Faculty of medicine Cairo university, Cairo, Egypt
Baskent University Medical School, Ankara, Turkey
Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, China
Kasralainy Faculty of Medicine, Cairo, Egypt
Taipei Veterans General Hospital, Taipei, Taiwan
Mount Sinai Hospital, Toronto, Ontario, Canada
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.